38
51
Growth Score
-11 pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
186118
Aditum Bio is an investment fund that specializes in acquiring and developing pharmaceutical assets.
Ilan Zipkin: Partner and VP, Business Development and LicensingPast Role: Takeda Ventures, Senior Investment Director
Mark Fishman: Co-Founder and Chair of the Scientific Advisory BoardAditum BioPast Role: Novartis, Founding President
About the Company
Aditum Bio is an investment fund that specializes in acquiring and developing pharmaceutical assets. It gives patients access to medicines that may not otherwise be developed. Aditum Bio was founded on 2019 and is headquartered in San Francisco, California.
Women Founded
